RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CHIARA S
Collezione AOU Città della Salute di Torino

Items : 6

The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course. in European urology focus / Eur Urol Focus. 2022 Nov;8(6):1847-1858. doi: 10.1016/j.euf.2022.01.018. Epub 2022 Feb 15.

2022
AOU Città della Salute di Torino
AOU Novara

Desai M; Artibani W; Sotelo R; Mitropoulos D; Shekhar Biyani C; Abreu A; Lebastchi A; Zaramella S; Verze P; Volpe A; Veneziano D; Umari P; Varca V; Pucci L; Sciorio C; Schiavina R; Pini G; Porreca A; Pastore AL; Chiara Sighinolfi M; Parma P; Minervini A; Gallo F; Greco F; Galfano A; Falsaperla M; Falabella R; Dalpiaz O; Ceruti C; et alii...

Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study. in Journal of geriatric oncology / J Geriatr Oncol. 2018 May;9(3):243-248. doi: 10.1016/j.jgo.2018.01.009. Epub 2018 Feb 9.

2018
AOU Città della Salute di Torino

Rosati G; Pinto C; Di Fabio F; Chiara S; Lolli IR; Ruggeri EM; Ciuffreda L; Ferrara R; Antonuzzo L; Adua D; Racca P; Bilancia D; Benincasa E; Stroppolo ME; Di Costanzo F;

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Apr 1;29(4):924-930. doi: 10.1093/annonc/mdy004.

2018
AOU Città della Salute di Torino

Dell'Aquila E; Cremolini C; Zeppola T; Lonardi S; Bergamo F; Masi G; Stellato M; Marmorino F; Schirripa M; Urbano F; Ronzoni M; Tomasello G; Zaniboni A; Racca P; Buonadonna A; Allegrini G; Fea E; Di Donato S; Chiara S; Tonini G; Tomcikova D; Boni L; Falcone A; Santini D;

Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study. in Cancer medicine / Cancer Med. 2016 Nov;5(11):3272-3281. doi: 10.1002/cam4.888. Epub 2016 Oct 17.

2016
AOU Città della Salute di Torino

Pinto C; Di Fabio F; Rosati G; Lolli IR; Ruggeri EM; Ciuffreda L; Ferrari D; Lo Re G; Rosti G; Tralongo P; Ferrara R; Alabiso O; Chiara S; Ianniello GP; Frassoldati A; Bilancia D; Campanella GA; Signorelli C; Racca P; Benincasa E; Stroppolo ME; Di Costanzo F;

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 May;27(5):843-9. doi: 10.1093/annonc/mdw052. Epub 2016 Feb 9.

2016
AO Cuneo
AOU Città della Salute di Torino

Bustreo S; Ronzoni M; Buonadonna A; Bergamo F; Tomasello G; Tonini G; Allegrini G; Vitello S; Rossini D; Moretto R; Chiara S; Mancini ML; Granetto C; Lonardi S; Masi G; Loupakis F; Cremolini C; Barbara C; Boni L; Falcone A;

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. in The New England journal of medicine / N Engl J Med. 2014 Oct 23;371(17):1609-18. doi: 10.1056/NEJMoa1403108.

2014
AOU Città della Salute di Torino

Loupakis F; Cremolini C; Masi G; Lonardi S; Zagonel V; Salvatore L; Cortesi E; Tomasello G; Ronzoni M; Spadi R; Zaniboni A; Tonini G; Buonadonna A; Amoroso D; Chiara S; Carlomagno C; Boni C; Allegrini G; Boni L; Falcone A;